Latest Market News

Contact Energy's October 2025 report reveals rising electricity and gas sales, improved netbacks, and reduced generation costs, supported by robust hydro storage and advancing renewable projects.

Serko Limited reports a robust 45% increase in total income for the first half of FY26, driven by its GetThere acquisition and strong momentum in Booking.com for Business, alongside a significant uplift in EBITDAFI.

Klevo Rewards Limited has been granted a crucial two-week extension by the ASX to meet reinstatement conditions and avoid automatic removal from the official list. The new deadline is now 1 December 2025.

RPMGlobal shareholders are set to vote on Caterpillar’s $5.00 per share acquisition proposal following Federal Court approval to convene a Scheme Meeting. The Independent Expert deems the offer fair and reasonable, with the RPM Board unanimously backing the deal.

Finder Energy Holdings has outlined ambitious plans to reach a Final Investment Decision by mid-2026 for its KTJ oil development, aiming for first oil production by late 2027 and unlocking over US$1 billion in gross revenues.

Finder Energy is accelerating development of its Kuda Tasi and Jahal fields in Timor-Leste, aiming for first oil by the end of 2027, backed by strong share price momentum and a clear pathway to production.

Antaria has disclosed several FDA-identified GMP compliance issues but assures no impact on product quality or supply, committing to expert-led remediation and enhanced training.

InFocus Group Holdings has extended its convertible note facility by $1 million, aiming to support growth in Thailand and new ventures in iGaming, pending shareholder approval.

Bank of Queensland has updated its dividend details, confirming a fully franked 20-cent payout for the half-year ending August 2025, alongside a refined Dividend Reinvestment Plan price and currency options for shareholders.

Shriro Holdings reported a 13.6% revenue decline in FY25 amid a strategic shift in its BBQ segment but delivered a 5.5% rise in EBITDA. The company plans a $20 million share buy-back in FY26, signaling confidence in its operational turnaround.

Paradigm Biopharmaceuticals has drawn down US$5 million under its convertible note facility to fund the accelerated expansion of its global Phase 3 trial for knee osteoarthritis treatment.

Sunrise Energy Metals has raised A$46 million through a strategic placement to advance pre-construction at its flagship Syerston Scandium Project, positioning itself as a key player in the scandium market amid supply uncertainties.